Print


ISIN and CFI Database for Non-Russian Financial Instruments that Meet the Requirements of Bank of Russia Regulation on Qualification

The Database contains ISIN and CFI codes allocated by authorized agencies in accordance with ISO 6166 and ISO 10962, and the CFI codes meet the requirements of paragraph 4.2 of the Directive of the Central Bank of the Russian Federation No. 4561-U dated October 3, 2017 "On the Procedure for the Qualification of Foreign Financial Instruments as Securities" (in the version of the Directive of Bank of Russia No. 4903-U dated 12.09.2018).

Information on non-Russian financial instruments is updated in real time as a result of processing clients' new requests relating to new instruments, and upon completion of NSD's daily monitoring of information on instruments already recorded in the Database.

Information on ISIN and CFI codes is provided by NSD to market participants solely for the purpose of qualification of non-Russian financial instruments as securities admitted for operations on the Russian market*.

 
Search key:
 
41981-42000 of 81021 results shown.
ISIN Issuer; Country Issue Description CFI Code Edition of IS0 10962 ISIN Status [?] Numbering Agency Information Source As of
US7171431015 PHAROL SGPS; PT SPONSORED ADR EDSXFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2022-09-06
US7171481002 PHARMANET DEV GROUP INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US71714F1049 PHARMERICA CORP; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US71714G1022 PHARMATHENE INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US71715B4095 PHARMION CORP; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US71715X2036 PHARMACYTE BIOTECH INC; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US71716E1055 PHARMING GROUP N V; NL ADR EDSXDR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US7171EM1089 PHARMACY CHAIN 36.6 PJSC; RU ADR EDSXFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US7172241090 PHASEBIO PHARMACEUTICALS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US71722R1086 PHAZAR CORP; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US71722W1071 PHATHOM PHARMACEUTICALS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US71723F1030 PHASERX INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US7172651025 PHELPS DODGE CORP; US COM ESXXXX 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US71742Q1067 PHIBRO ANIMAL HEALTH CORP; US CL A COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US7181721090 PHILIP MORRIS INTL INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US718172AC39 PHILIP MORRIS INTL INC; US NT DBFUGR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US718172AH26 PHILIP MORRIS INTL INC; US NT DBFUGR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US718172AS80 PHILIP MORRIS INTL INC; US NT DBFUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US718172AT63 PHILIP MORRIS INTL INC; US NT DBFUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US718172AU37 PHILIP MORRIS INTL INC; US NT DBFUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26

* NSD does not make any representation or warranty as to the completeness or reliability of the information contained herein, nor does it make any warranty regarding its consistency with the purposes for which the information is used, including but not limited to, commercial purposes. The information published on this website is not to be construed as an offer to effect any deal with financial instruments, and should not be used for commercial or other purposes; nor does it represent an offer from NSD to render any services; nor does it make any warranty or representation of reliability of certain financial instruments or persons (including but not limited to, issuers, securities market participants, etc.).


For further information, please refer to NSD’s experts.

Printed version

Print